Abstract
N,N-dipropyl-5,6-dihydroxyaminotetralin (DP-5,6-ADTN) is a potent DA-agonist both in vivo and in vitro (Feenstra et al., 1980).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feenstra, M.G.P., H. Rollema, A.S. Horn, D. Dijkstra, C.J. Grol, B.H.C. Westerink and A. Westerbrink (1980). Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum. Naunyn Schmiedeberg’s Arch. Pharmacol., 310, 219.
Feenstra, M.G.P., H. Rollema, T.B.A. Mulder, B.H.C. Westerink and A.S. Horn (1983). In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN. Life Sci., 32, 1313.
Leff, S.E. and I. Creese (1983). Dopamine receptors re-explained. Trends in Pharmacol Sci., 4, 463.
Zivin, J.V. and D.R. Waud (1982). How to analyze binding, enzyme and uptake data: The simplest case, a single phase. Life Sci., 30, 1407.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1986 The Contributors
About this chapter
Cite this chapter
Mulder, T.B.A., Grol, C.J., Dijkstra, D., Horn, A.S. (1986). Characterization of the in vitro Binding of [3H] DP-5,6-ADTN to Rat Striatal Membranes. In: Woodruff, G.N., Poat, J.A., Roberts, P.J. (eds) Dopaminergic Systems and their Regulation. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07431-0_41
Download citation
DOI: https://doi.org/10.1007/978-1-349-07431-0_41
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07433-4
Online ISBN: 978-1-349-07431-0
eBook Packages: MedicineMedicine (R0)